ATNT-05 INTRAOPERATIVE INTRAPARENCHYMAL INJECTION OF IRINOTECAN DRUG LOADED BEADS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): A SAFE NEW DEPOT APPROACH FOR LOCO-REGIONAL THERAPY (NCT02433392)

Lignende værker

• PP44. SURGICAL IMPLANTATION OF IRINOTECAN LOADED MICRO-BEADS OFFERS A NOVEL SAFE APPROACH TO TREATING PATIENTS WITH RECURRENT GLIOBLASTOMA(NCT02433392)
  af: Cruickshank, Prof Garth, et al.
  Udgivet: (2017)
• Local Delivery Of Irinotecan To Recurrent Glioblastoma At Reoperation Offers A Safe Therapeutic Advantage Over Systemic Delivery
  af: Cruickshank, Garth, et al.
  Udgivet: (2018)
• ET-14 OPTIMISATION OF BORONOPHENYLALANINE (BPA) DELIVERY AND LAT1 EXPRESSION FOR THE CLINICAL APPLICATION OF BORON NEUTRON CAPTURE THERAPY (BNCT) IN GLIOBLASTOMA
  af: Cruickshank, Garth, et al.
  Udgivet: (2014)
• Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM
  af: Jaeckle, Kurt A., et al.
  Udgivet: (2010)
• OP12 BORON NEUTRON CAPTURE THERAPY (BNCT): OPTIMISATION OF BORON UPTAKE AND PATIENT STRATIFICATION BY LAT1 IMPROVES BIOLOGICAL TARGETING WITH REDUCED RADIATION TIME, AND INCREASED CHANCE OF TUMOUR CONTROL
  af: Cruickshank, G., et al.
  Udgivet: (2014)